IL22 and colorectal carcinoma: Induces proliferation of enterocytes and dysplasia in a mouse model of IBD-CRC. IL-22 induces the nitric oxide synthase that leads to nitric oxide production within crypt epithelial cells driving DNA damage and carcinogenesis.